75 related articles for article (PubMed ID: 9543121)
21. New strategies for the treatment of secondary hyperparathyroidism.
Akizawa T; Shiizaki K; Hatamura I; Kamimura M; Mizobuchi M; Narukawa N; Sumikado S; Sakaguchi T; Negi S; Ogata H; Kinugasa E
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S100-3. PubMed ID: 12612963
[TBL] [Abstract][Full Text] [Related]
22. Effect of calcium supplementation on bone mass in patients operated on for hyperparathyroidism.
Abugassa S; Järhult J; Nordenström J
Eur J Surg; 1991 May; 157(5):313-7. PubMed ID: 1678643
[TBL] [Abstract][Full Text] [Related]
23. Bone mineral density increases with vitamin D repletion in patients with coexistent vitamin D insufficiency and primary hyperparathyroidism.
Kantorovich V; Gacad MA; Seeger LL; Adams JS
J Clin Endocrinol Metab; 2000 Oct; 85(10):3541-3. PubMed ID: 11061498
[TBL] [Abstract][Full Text] [Related]
24. Manipulating the calcium receptor.
Sherrard DJ
J Am Soc Nephrol; 2002 Apr; 13(4):1124-1125. PubMed ID: 11912275
[No Abstract] [Full Text] [Related]
25. Cinacalcet hydrochloride (Amgen).
Iqbal J; Zaidi M; Schneider AE
IDrugs; 2003 Jun; 6(6):587-92. PubMed ID: 12811682
[TBL] [Abstract][Full Text] [Related]
26. Achieving therapeutic targets in the treatment of secondary hyperparathyroidism.
Cunningham J
Nephrol Dial Transplant; 2004 Aug; 19 Suppl 5():V9-14. PubMed ID: 15284354
[TBL] [Abstract][Full Text] [Related]
27. [Basic and clinical aspects of calcimimetics. Treatment of secondary hyperparathyroidism in dialysis patients with calcimimetics].
Tanaka M; Fukagawa M
Clin Calcium; 2008 Jan; 18(1):89-93. PubMed ID: 18175877
[TBL] [Abstract][Full Text] [Related]
28. Effect of calcium supplementation on bone density and parathyroid function in elderly subjects.
Fujita T; Ohue T; Fujii Y; Miyauchi A; Takagi Y
Miner Electrolyte Metab; 1995; 21(1-3):229-31. PubMed ID: 7565455
[TBL] [Abstract][Full Text] [Related]
29. In reply to "Etiology of hyperparathyroidism in McCune-Albright syndrome".
Chen Y; Ding X
J Oral Maxillofac Surg; 2010 Apr; 68(4):949-50. PubMed ID: 20307782
[No Abstract] [Full Text] [Related]
30. Neonatal hyperparathyroidism with a heterozygous calcium-sensing receptor (CASR) R185Q mutation: clinical benefit from cinacalcet.
Reh CM; Hendy GN; Cole DE; Jeandron DD
J Clin Endocrinol Metab; 2011 Apr; 96(4):E707-12. PubMed ID: 21289269
[TBL] [Abstract][Full Text] [Related]
31. Cinacalcet decreases bone formation rate in hypercalcemic hyperparathyroidism after kidney transplantation.
Borchhardt KA; Diarra D; Sulzbacher I; Benesch T; Haas M; Sunder-Plassmann G
Am J Nephrol; 2010; 31(6):482-9. PubMed ID: 20431285
[TBL] [Abstract][Full Text] [Related]
32. Estrogens and progestins in the management of primary hyperparathyroidism.
Marcus R
J Bone Miner Res; 1991 Oct; 6 Suppl 2():S125-9; discussion S151-2. PubMed ID: 1763663
[TBL] [Abstract][Full Text] [Related]
33. Treatment of postmenopausal hyperparathyroidism with norethindrone. Effects on biochemistry and forearm mineral density.
Horowitz M; Wishart J; Need AG; Morris H; Philcox J; Nordin BE
Arch Intern Med; 1987 Apr; 147(4):681-5. PubMed ID: 3827457
[TBL] [Abstract][Full Text] [Related]
34. [Hyper- and hypoparathyroidism].
Kuhlencordt F
Dtsch Med J; 1969 Feb; 20(4):113-7. PubMed ID: 5778533
[No Abstract] [Full Text] [Related]
35. [Changes in calcium metabolism after parathyroidectomy in primary hyperparathyroidism].
Berczi C; Balogh A; Balázs G; Lukács G
Orv Hetil; 2002 Mar; 143(12):597-600. PubMed ID: 11963396
[TBL] [Abstract][Full Text] [Related]
36. Bisphosphonate therapy in primary hyperparathyroidism.
Hershman JM; Hassani S; Braunstein GD; Geola F; Brickman A; Seibel MJ
J Bone Miner Res; 2003 Oct; 18(10):1889; author reply 1890. PubMed ID: 14584900
[No Abstract] [Full Text] [Related]
37. Novel calcium sensing receptor ligands: a patent survey.
Kiefer L; Leiris S; Dodd RH
Expert Opin Ther Pat; 2011 May; 21(5):681-98. PubMed ID: 21406038
[TBL] [Abstract][Full Text] [Related]
38. Cinacalcet for the treatment of primary hyperparathyroidism.
Dillon ML; Frazee LA
Am J Ther; 2011 Jul; 18(4):313-22. PubMed ID: 20228675
[TBL] [Abstract][Full Text] [Related]
39. Metabolic bone disease of prematurity and secondary hyperparathyroidism.
Lothe A; Sinn J; Stone M
J Paediatr Child Health; 2011 Aug; 47(8):550-3. PubMed ID: 21392146
[TBL] [Abstract][Full Text] [Related]
40. [Calcimimetics: no competition for surgery in primary hyperparathyroidism].
Lorenz K
Chirurg; 2012 Apr; 83(4):384. PubMed ID: 22415492
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
